Jerome B. Zeldis, Director at PTC THERAPEUTICS, INC. (PTCT), sold 20,000 shares at $38.24 ($765K) on 2024-05-22, disclosed to the SEC on 2024-05-24.
Scheduled sale ($765k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NXGL | BUY | 2024-08-27 | $25K | — | Filing → |
| NXGL | BUY | 2023-05-30 | $12K | — | Filing → |
| NXGL | BUY | 2022-03-28 | $10K | — | Filing → |